Autonomix Medical, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G/A: Autonomix Medical: Key Investors Divest All Shares
Several investment funds and their principals have reported divesting their entire beneficial ownership in Autonomix Medical, Inc., reducing their stake to 0%.
NASDAQ
BioStar Ventures III, L.P. and its general partner have reduced their beneficial ownership in Autonomix Medical, Inc. to 4.3% of common stock.
NASDAQ
SCHEDULE 13G/A: Investment Funds Disclose 4.9% Stake in Autonomix Medical
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a beneficial ownership of 4.9% in Autonomix Medical, Inc., totaling 116,087 shares.